Chronic kidney disease stage 3 Chronic kidney disease stage 3 Self-
Conditions
Interventions
In the experimental group,
twenty participants receive usual care from the CKD clinic at Samut Prakan Hospital plus a self-
management support integrated with the mHealth application program. The researchers and RA2 will deliver the program following the protocol. The program consists of four sessions over four weeks as fo
specific factors,
physical/social environment,
and individual/family factors that can be a possible risk or protective factor. The researcher will conduct the program individually in the first week,
spending approximately 30 minutes in a private room at the CKD clinic,
Samut Prakan Hospital.
Session 2 (week 2): Providing knowledge and caring beliefs of the participants and family members. This session aims to improve the participant and family members'
knowledge to increase understanding and self-
confidence to manage CKD. The researchers and RA2 will conduct the program on a small group of 10-
12 person/group (participant 5-
6 person and family member 5-
6 person) in the second week,
spending approximately 60 minutes in a private room at the CKD clinic,
Samut Prakan Hospital. The essentials topic for CKD knowledge consisting of causes,
signs and symptoms,
complications,
treatment,
management guidelines to delay renal degeneration (Nephrology Society of Thailand,
Sponsors
An Ethics Committee on Human Research, Research and Innovation Admisnistration Division
Faculty of Nursing,
Burapha University
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1) Patients aged 18-79 years and family member 2) CKD stage 3a (eGFR = 45-59 ml/min/1.73 m2) or 3b (eGFR = 30-44 ml/min/1.73 m2) 3) Co-morbidity diseases which controllable (using clinical parameters from medical history). For example, a person with hypertension must have blood pressure < 180/110 mmHg and without symptoms of hypertensive urgency or hypertensive crisis. A person with diabetes mellitus must have a blood sugar (FBS) level ≤ 250 mg/dl and without diabetic ketoacidosis etc. 4) Without cognitive impairment which screened by the Thai mental state examination (TMSE) 5) Having a mobile phone and ability in using mobile phone applications and internet access 6) Ability to read and write in Thai 7) Reside in Samut Prakan Province
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) The participants have advanced to stage 4 or 5 of CKD during the program. 2) The participants are having adjusted to increase the dose of the antihypertensive drug during the program. Termination criteria: 1) The participants have a severe illness or are in a critical phase and must be hospitalized during the program. 2) The participants died during the program. Withdrawal criteria: 1) The participants request to withdraw because they are inconvenient to participate in the research project as scheduled.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-Management Behaviors Baseline, post intervention at week 4, and follow up at week 12 The Self-Management Behaviors Questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure and Estimated Glomerular Filtration Rate Baseline, post intervention at week 4, and follow up at week 12 The Clinical Outcomes Record Form | — |
Countries
Thailand
Contacts
Public ContactKhemaradee Masingboon
Burapha University
Outcome results
None listed